STOK
USDStoke Therapeutics Inc. Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$25.000
高値
$25.550
安値
$24.660
出来高
0.81M
企業ファンダメンタルズ
時価総額
1.4B
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
1.17M
取引所
NMS
通貨
USD
52週レンジ
AI分析レポート
最終更新: 2025年10月30日Stoke Therapeutics (STOK): Riding Wave of Biotech Optimism, But Risks Lurk
Price Action: Volatility With Clear Upside Momentum
The stock has swung between $12.40 and $38.69 over the past 90 days, reflecting high sensitivity to news. Key patterns:
- Explosive breakout in October (up 34% from $20.68 to $27.31 in 4 days, then a dramatic spike to $38.69 on Oct 16)
- Recent correction (-4.3% from Oct 22 to 29) followed by a small rebound on Oct 30 (closing at $31.66 vs. $31.41 open)
- Volume surged to 4x average during the October rally, showing strong institutional interest
News Impact: Positive Clinical Data Drives Surge
Three catalysts fueled the October rally:
関連ニュース
BTIG Reiterates Buy on Stoke Therapeutics, Maintains $39 Price Target
BTIG analyst Thomas Shrader reiterates Stoke Therapeutics with a Buy and maintains $39 price target.
JP Morgan Maintains Neutral on Stoke Therapeutics, Raises Price Target to $25
JP Morgan analyst Jessica Fye maintains Stoke Therapeutics with a Neutral and raises the price target from $15 to $25.
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in
AI予測Beta
AI推奨
更新日時: 2025年11月5日 09:53
69.8% 信頼度
リスクと取引
エントリーポイント
$29.88
利確
$32.14
損切り
$27.01
主要因子
関連株式
EOI
Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
VCEL
Vericel Corporation
MCAA
Mountain & Co. I Acquisition Corp. Ordinary Shares
GWRE
Guidewire Software Inc.
CVX
Chevron Corporation
最新情報を入手
価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。